Alexandria Real Estate Equities
ARE
Market cap $18.3B

104.93 USD

-3.09

2.86%

At close Dec 4, 4:00 PM EST

Pre-market

105.41

+0.48

0.46%

1 day

-2.86%

5 days

-5.37%

1 month

-7.13%

3 months

-10.77%

6 months

-10.71%

Year to date

-18.85%

1 year

-12.48%

5 years

-34.45%

10 years

19.08%

About: Alexandria Real Estate Equities Inc is an urban office real estate investment trust (REIT). It is engaged in the business of providing space for lease to life science, agtech, and technology tenants. The company has established a significant market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. Alexandria has a longstanding and proven track record of developing Class A properties clustered in urban life science, agtech, and technology campuses that provide tenants with highly dynamic and collaborative environments. Alexandria also provides strategic capital to transformative life science, agtech, and technology companies through venture capital platform.

Employees: 568

Financials Real Estate Investment Trusts

0

Funds holding %

of 6,790 funds

0

Analysts bullish %

of 8 analysts

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

17% more call options, than puts

Call options by funds: $88.9M | Put options by funds: $76.1M

5% more repeat investments, than reductions

Existing positions increased: 257 | Existing positions reduced: 244

3% less funds holding

Funds holding: 658 [Q2] → 635 (-23) [Q3]

12% less capital invested

Capital invested by funds: $19.2B [Q2] → $17B (-$2.26B) [Q3]

12.12% less ownership

Funds ownership: 94.05% [Q2] → 81.92% (-12.12%) [Q3]

20% less funds holding in top 10

Funds holding in top 10: 5 [Q2] → 4 (-1) [Q3]

25% less first-time investments, than exits

New positions opened: 70 | Existing positions closed: 93

See Fund Rankings

Research analyst outlook

8 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$120

14%

upside

Avg. target

$125

19%

upside

High target

$130

24%

upside

8 analyst ratings

2 positive

25%

6 neutral

75%

0 negative

0%

JP Morgan Anthony Paolone 46% 1-year accuracy 6 / 13 met price target	15%upside $121	Neutral Downgraded	27 Nov 2024
JMP Securities Aaron Hecht 64% 1-year accuracy 18 / 28 met price target	24%upside $130	Market Outperform Maintained	15 Nov 2024
Baird David Rodgers 80% 1-year accuracy 8 / 10 met price target	24%upside $130	Outperform Maintained	8 Nov 2024
RBC Capital Michael Carroll 47% 1-year accuracy 9 / 19 met price target	19%upside $125	Sector Perform Downgraded	25 Oct 2024
RBC Capital Michael Carroll 47% 1-year accuracy 9 / 19 met price target	19%upside $125	Sector Perform Downgraded	24 Oct 2024

See Analyst Rankings

Financial journalist opinion

Based on 15 articles about ARE published over the past 30 days

Buy Alert: 2 REITs To Buy Before 2025

2024 was a great year. We think that 2025 will be similar. We highlight 2 high-quality REITs to buy today.

Buy Alert: 2 REITs To Buy Before 2025

The 8 Stocks And 1 ETF On My Buy List Going Into December

The market outlook for 2025 is uncertain, with a wide range of possibilities in GDP growth, inflation, and job growth. Government spending cuts led by Elon Musk and Vivek Ramaswamy's DOGE initiative are unlikely to meet their ambitious $2 trillion goal due to mandatory spending constraints. Significant cash reserves, like Berkshire Hathaway's $325 billion, suggest potential market caution, but a drop in the Fed Funds Rate below 4% could boost REITs and bonds.

The 8 Stocks And 1 ETF On My Buy List Going Into December

Zacks Investment Research

Is it Wise to Retain Alexandria Stock in Your Portfolio Now?

ARE's premium Class A/A+ properties, buyouts and a healthy balance sheet position bode well. A significant development pipeline poses concerns.

Is it Wise to Retain Alexandria Stock in Your Portfolio Now?

3 "AI Income Machines" Leaving the Magnificent Seven in the Dust

For almost two years now, stocks that tap into the global $15.7 trillion AI revolution have surged so quickly, the media has a nickname for them: the "Magnificent Seven."

3 "AI Income Machines" Leaving the Magnificent Seven in the Dust

Bad News For REITs, Good News For High Income Investors

Many of us expected REITs to explode higher when the Fed would start to decrease interest rates. Rising long-term yields have quite quickly destroyed these expectations. In this article, I describe two indicators, which imply elevated risks for REITs. In my view, the risks are high for REITs to decline.

Bad News For REITs, Good News For High Income Investors

Alexandria: It's Lonely When You're A Value Investor, But That's Okay With Me

As a value investor, I thrive on identifying mispriced companies like Tanger and Iron Mountain, which have yielded impressive returns of 426% and 440%, respectively. Alexandria Real Estate is a fundamentally strong, BBB+ rated REIT with a 5% yield, low leverage, and high tenant loyalty, making it a "Strong Buy". ARE's historical performance, superior operating results, and conservative management justify a valuation target of $160/share, with potential annual returns of 30-50%.

Alexandria: It's Lonely When You're A Value Investor, But That's Okay With Me

7 Stocks I'm Buying In Defiance Of Post-Election Euphoria

Some stock sectors exhibit dangerous euphoria, reminiscent of Icarus flying too close to the sun, risking a significant correction. Post-election optimism has inflated valuations in midstream energy, regional banks, investment banks, and insurance companies, raising concerns about sustainability. The threat of mass deportations could impact agricultural REITs like Gladstone Land, affecting labor supply and lease structures.

7 Stocks I'm Buying In Defiance Of Post-Election Euphoria

Zacks Investment Research

Alexandria Announces Long-Term Lease at San Carlos Mega Campus

ARE announces that it has executed a 10-year lease with Vaxcyte, Inc., a clinical-stage biopharmaceutical company.

Alexandria Announces Long-Term Lease at San Carlos Mega Campus

Alexandria Real Estate Equities, Inc. Announces Long-Term 258,581 RSF Lease With Longstanding Tenant Vaxcyte, Inc. at the Alexandria Center for Life Science - San Carlos Mega Campus

PASADENA, Calif. , Nov. 21, 2024 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), the first, preeminent, longest-tenured and pioneering owner, operator and developer of collaborative mega campuses in AAA life science innovation cluster locations, today announced that it executed a 10-year lease with Vaxcyte, Inc., a clinical-stage biopharmaceutical company working to protect humankind from the consequences of bacterial diseases, for a total of 258,581 RSF at 825 Industrial Road on the Alexandria Center® for Life Science – San Carlos mega campus in the San Francisco Bay Area.

Alexandria Real Estate Equities, Inc. Announces Long-Term 258,581 RSF Lease With Longstanding Tenant Vaxcyte, Inc. at the Alexandria Center for Life Science - San Carlos Mega Campus

Alexandria Real Estate: Buy The Dip And Start The DRIP

Dividend reinvestment in high-quality stocks at below-average valuations like Alexandria Real Estate can result in potentially strong total returns. ARE's focus on mega campuses in innovation clusters results in sticky tenant relationships, robust leasing activity, and stable occupancy levels. ARE carries a strong balance sheet, attractive 4.9% dividend yield, and significant development pipeline, positioning it for solid future growth.

Alexandria Real Estate: Buy The Dip And Start The DRIP

See News Rankings

Charts implemented using Lightweight Charts™